Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort studyFrancesco Passamonti, Celestino Ferrandina, Roberto Cairoli et al.|The Lancet Haematology|2020Cited by 553
Complete response correlates with long-term progression-free and overall survival in elderly myeloma treated with novel agents: analysis of 1175 patientsFrancesca Gay, Antonio Palumbo, Alessandra Larocca et al.|Blood|2011Cited by 268
High XBP1 expression is a marker of better outcome in multiple myeloma patients treated with bortezomibManuela Gambella, Antonio Palumbo, Roberto Passera et al.|Haematologica|2014Cited by 56
The prognostic value of the myeloid-mediated immunosuppression marker Arginase-1 in classic Hodgkin lymphomaAlessandra Romano, Francesco Di Raimondo|Oncotarget|2016Cited by 40